Future of risk based monitoring in clinical trials

Drug development is a complex and resource intensive endeavor. The average cost of developing a new drug, has been estimated to be $2 to $3 billion. However, the success rate of clinical trials is very low around and is estimated to be between 3-5%. The common reasons for failure of clinical trials...

Full description

Saved in:
Bibliographic Details
Published inInternational Journal of Clinical Trials Vol. 7; no. 3; p. 221
Main Author Vyas, Niraj R.
Format Journal Article
LanguageEnglish
Published 21.07.2020
Online AccessGet full text

Cover

Loading…